Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver, Colorado 80218


Purpose:

There is a need to identify and test effective strategies to reduce meth use and human immunodeficiency virus (HIV) risk behaviors in heterosexuals. This project will compare the efficacy of a manually-driven HIV testing and counseling (HIV T/C) intervention, with HIV T/C plus a manualized Contingency Management (CM), with HIV T/C plus CM plus a manualized Strengths-Based Case Management (CM/SBCM) model. As HIV T/C is the standard of care, the investigators are testing to determine if the investigators can enhance this standard. The specific aims and hypotheses of this protocol are: 1. To compare the relative efficacy of HIV T/C vs. CM vs. CM/SBCM on reducing drug use, specifically meth use. Hypothesis 1: CM/SBCM will reduce drug use more than those in CM (which will have more reduction than HIV T/C), potentially mediated through increased service utilization. 2. To compare the relative efficacy of HIV T/C vs. CM vs. CM/SBCM on reducing HIV and STI risk behaviors, specifically sex risk behaviors but also needle risk for injection drug users (IDUs). Hypothesis 2: CM/SBCM will have greater decreases in HIV risk behaviors than those in CM (which will have greater decreases than HIV T/C), potentially mediated through reduced drug use. 3. To compare the relative efficacy of HIV T/C vs. CM vs. CM/SBCM on improving mental health status. Hypothesis 3: CM/SBCM will have greater improvements in mental health status than those in CM (which will have greater improvements than HIV T/C), potentially mediated through increased service utilization and reduction of drug use, and potentially moderated by baseline meth use.


Criteria:

Inclusion Criteria: - 18 years of age or older - Be competent (not too intoxicated or mentally disabled) to give informed consent at the time of the interview - Meth use (verified through urine drug screening and a self-report of meth use of at least 4 times per month for the last 3 months) - Self-reported sex with someone of the opposite sex in last 30 days - Ability to provide a reliable address and phone number for contact - Not in drug treatment in the past 30 days - Willingness to be tested for HIV at baseline and follow-up - Not transient and no know reason why he/she will not be available for follow-up interviews - Not currently mandated by the criminal justice system to receive treatment based on self-report. Exclusion Criteria: - Participation in drug treatment in the past 30 days - Currently participating in another Project Safe study - Pregnant or attempting to become pregnant - Intoxicated or impaired mentally to the point that they cannot voluntarily consent to participate tin the project and/or respond to the interview


NCT ID:

NCT01161485


Primary Contact:

Principal Investigator
Karen F Corsi, ScD, MPH
University of Colorado, Denver


Backup Contact:

N/A


Location Contact:

Denver, Colorado 80218
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.